Velvet antler polypeptide (VAP) protects against cerebral ischemic injury through NF-κB signaling pathway in vitro.

MLA

Wu, Qian, et al. “Velvet Antler Polypeptide (VAP) Protects against Cerebral Ischemic Injury through NF-ΚB Signaling Pathway in Vitro.” Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, vol. 33, no. 5, May 2024, p. 107666. EBSCOhost, https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107666.

APA

Wu, Q., Li, Y., Ye, R., Wang, H., & Ge, Y. (2024). Velvet antler polypeptide (VAP) protects against cerebral ischemic injury through NF-κB signaling pathway in vitro. Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, 33(5), 107666. https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107666

Chicago

Wu, Qian, Yutao Li, Ru Ye, Hui Wang, and Ying Ge. 2024. “Velvet Antler Polypeptide (VAP) Protects against Cerebral Ischemic Injury through NF-ΚB Signaling Pathway in Vitro.” Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association 33 (5): 107666. doi:10.1016/j.jstrokecerebrovasdis.2024.107666.